Tuesday, November 24, 2009, 4:25AM AEST - The Australian Stockmarket opens in 5 hours and 35 minutes.
To create a watchlist or portfolio of shares, Register

Par Pharmaceutical Companies Inc. (PRX)

4:10AM AEST: 23.98 USD  Up 0.53 (2.26%)  
 MORE ON PRX 
Quotes
HereSummary
Charts
Technical Analysis
News & Info
Company
Analyst Coverage
Ownership
Financials
 PHARMACUTICAL CO (NYSE:PRX) Delayed quote dataEdit
Last Trade:23.98 USD
Trade Time: 4:10AM AEST
Change:Up 0.53 (2.26%)
Prev Close:23.45
Open:23.74
Bid:N/A
Ask:N/A
1y Target Est:26.43
Day's Range:23.66 - 24.13
52wk Range:7.91 - 24.23
Volume:299,494
Avg Vol (3m):506,174
Market Cap:834.96M
P/E (ttm):21.47
EPS (ttm):1.12
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
 Add PRX to Portfolio   Download Data

 HEADLINES 
Drugmaker Par Shapes A Base But Needs Time
Investor's Business Daily (Sat, Nov 21)
Par Pharmaceutical to Host Analyst Day on December 3rd
PR Newswire (Tue, Nov 17)
Par Pharma gets FDA approval for generic Ultram ER
AP (Tue, Nov 17)
UPDATE - Par Pharma gets FDA nod for generic version of Ultram
at Reuters (Tue, Nov 17)
Par Pharmaceutical Receives Final Approval to Market Generic Ultram(R) ER
PR Newswire (Tue, Nov 17)
PAR PHARMACEUTICAL COMPANIES, INC. Financials
EDGAR Online Financials (Sat, Nov 14)
[$$] Biotech Stock Mailbag: Cardium Therapeutics
at RealMoney by TheStreet.com (Fri, Nov 13)
New Star Analyst Rankings for PHARMACUTICAL CO
StarMine (Wed, Nov 11)
Par Pharmaceutical Announces Extension and Increase in Maximum Purchase Price for 'Modified Dutch Auction' Tender Offer to Purchase up to $65,000,000 Aggregate Principal Amount of its Currently Outstanding 2.875% Senior Subordinated Convert
PR Newswire (Tue, Nov 10)
Par 3Q profit surges on product sales
AP (Sat, Nov 7)
More Headlines for PRX...

 ANALYST 
EPS Est (next year) (Dec-09) :2.46
EPS Est (in 2 years) (Dec-10) :1.60
Avg Rec (current)*:2.3
PEG Ratio:0.18
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Par Pharmaceutical Companies, Inc., through its subsidiary, Par Pharmaceutical, Inc. develops, manufactures, and distributes generic and branded pharmaceuticals drugs in the United States.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
Latest News7 Indices